Novartis AG (TSX:NVS)
28.45
+0.45 (1.61%)
Oct 9, 2026, 10:39 AM EST
Novartis AG Employees
Novartis AG had 75,267 employees as of December 31, 2025. The number of employees decreased by 616 or -0.81% compared to the previous year.
Employees
75,267
Change (1Y)
-616
Growth (1Y)
-0.81%
Revenue / Employee
1.07M CAD
Profits / Employee
240.69K CAD
Market Cap
388.78B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75,267 | -616 | -0.81% |
| Dec 31, 2024 | 75,883 | -174 | -0.23% |
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Jun 30, 2023 | 103,000 | -5,000 | -4.63% |
| Mar 31, 2023 | 103,000 | -7,000 | -6.36% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Sep 30, 2022 | 108,000 | 0 | - |
| Jun 30, 2022 | 108,000 | -1,000 | -0.92% |
| Mar 31, 2022 | 110,000 | 0 | - |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Sep 30, 2021 | 108,000 | -2,000 | -1.82% |
| Jun 30, 2021 | 109,000 | -1,000 | -0.91% |
| Mar 31, 2021 | 110,000 | 1,000 | 0.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 4,900 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
| Cronos Group | 610 |
Novartis AG News
- 2 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS - PRNewsWire
- 2 days ago - Novartis Wins FDA Approval For First Symptomatic Dermographism Treatment - Nasdaq
- 3 days ago - Novartis (NVS) Secures FDA Approval for Rhapsido, Expanding Treatment Options for Chronic Hives - GuruFocus
- 3 days ago - US FDA expands use of Novartis drug for chronic skin condition - Reuters
- 3 days ago - Novartis announces FDA approval of Rhapsido for symptomatic dermographism - TheFly
- 3 days ago - Novartis to present data from MS portfolio with 46 abstracts at MSToronto2026 - TheFly
- 3 days ago - AI companies run virtual drug trials, aim to improve success of human studies - Reuters
- 4 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS - GlobeNewsWire